Bay 60-7550 25mg 25mg | Purity Not Available
Adooq Bioscience
BAY 60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).
More Information Supplier PageSearch Results
Bay 60-7550 10mg 10mg | Purity Not Available
Adooq Bioscience
BAY 60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).
More Information Supplier PageBCX 1470 methanesulfonate 5mg 5mg | Purity Not Available
Adooq Bioscience
BCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 methanesulfonate 25mg 25mg | Purity Not Available
Adooq Bioscience
BCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 methanesulfonate 2mg 2mg | Purity Not Available
Adooq Bioscience
BCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBCX 1470 methanesulfonate 10mg 10mg | Purity Not Available
Adooq Bioscience
BCX 1470 is serine protease inhibitor. BCX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro.
More Information Supplier PageBardoxolone (CDDO) 50mg 50mg | Purity Not Available
Adooq Bioscience
Bardoxolone methyl, previously known as RTA 402, is the lead molecule in Reata’s portfolio of Antioxidant Inflammation Modulators (AIMs).
More Information Supplier PageBardoxolone (CDDO) 25mg 25mg | Purity Not Available
Adooq Bioscience
Bardoxolone methyl, previously known as RTA 402, is the lead molecule in Reata’s portfolio of Antioxidant Inflammation Modulators (AIMs).
More Information Supplier PageBay 60-7550 50mg 50mg | Purity Not Available
Adooq Bioscience
BAY 60-7550 is a potent PDE2 inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human).
More Information Supplier PageBYL719 10mg 10mg | Purity Not Available
Adooq Bioscience
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity.
More Information Supplier Page